Back to top
more

Inogen (INGN)

(Real Time Quote from BATS)

$6.34 USD

6.34
94,498

-0.20 (-3.06%)

Updated Aug 5, 2025 02:26 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (158 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Community Health Prices Senior Secured Notes Worth $2.2B

by Zacks Equity Research

Community Health Systems, Inc. (CYH) recently announced that it has issued 6.25%, $2.2 billion Senior Secured Notes, due 2023. The offering was upsized by $450 million.

    Zacks Equity Research

    CVS Health Adopts Epic EHR for Specialty Care Programs

    by Zacks Equity Research

    CVS Health Corporation (CVS) recently announced that it has chosen Epic as the electronic health record (EHR) system for CVS Specialty's care management programs.

      Zacks Equity Research

      BioScrip (BIOS): Q4 Loss Narrower than Expected, Sales Top

      by Zacks Equity Research

      BioScrip, Inc. (BIOS) reported net loss from continuing operations of $5.2 million or loss of 6 cents per share in the fourth quarter of 2016, much narrower than the year-ago net loss of $16.9 million or loss of 28 cents.

        Zacks Equity Research

        Inogen (INGN) Tops Earnings & Revenues in Q4; View Upbeat

        by Zacks Equity Research

        Inogen Inc. (INGN) reported fourth-quarter 2016 earnings of 25 cents per share, which surpassed both the Zacks Consensus Estimate by 15 cents and the year-ago figure by 11 cents.

          Zacks Equity Research

          athenahealth (ATHN) Beats on Q4 Earnings, Misses Revenues

          by Zacks Equity Research

          athenahealth (ATHN) reported adjusted earnings of 42 cents per share, which beat the Zacks Consensus Estimate of 27 cents.

            Zacks Equity Research

            PerkinElmer (PKI) Misses Q4 Earnings & Revenue Estimates

            by Zacks Equity Research

            Waltham, MA-based PerkinElmer Inc (PKI) reported fourth-quarter 2016 earnings of 83 cents per share missing the Zacks Consensus Estimate of 86 cents

              Zacks Equity Research

              CONMED (CNMD) Q4 Earnings Miss Estimates, Increase Y/Y

              by Zacks Equity Research

              Headquartered in Utica, NY, leading medical technology player, CONMED Corporation (CNMD) reported fourth-quarter 2016 adjusted earnings of 54 cents per share, missing the Zacks Consensus Estimate by 2 cents.

                Zacks Equity Research

                Baxter International (BAX) Q4 Earnings Beat, Revenues Lag

                by Zacks Equity Research

                Baxter International Inc. (BAX) reported fourth-quarter 2016 adjusted earnings of 57 cents per share, which surpassed the Zacks Consensus Estimate by 5 cents and were well above the year-ago figure of 43 cents.

                  Zacks Equity Research

                  Glaukos (GKOS) Catches Eye: Stock Adds 5.6% in Session

                  by Zacks Equity Research

                  Glaukos Corporation (GKOS) moved big last session, as its shares jumped almost 6% on the day.

                    Zacks Equity Research

                    Inogen (INGN) Affirms Outlook and Shuffles Top Management

                    by Zacks Equity Research

                    Inogen, Inc. (INGN) reiterated its fiscal 2016 outlook and appointed a new President cum Chief Executive Officer.

                      Kevin Matras headshot

                      Top Stocks with Big Potential Catch-Up Moves

                      by Kevin Matras

                      Given the recent run-up in the market, here's a screen I've been using recently. Highlighted stocks include CSGP, CW, HLS, INGN and PKI.